Nepal has confirmed two additional cases of mpox among migrant workers, according to health authorities on Friday. With the ...

These two mpox cases point to the hazardous conditions and risky behaviours of Nepali migrant workers. Several international ...

On Thursday, the Japan Ministry of Health, Labour and Welfare approved SIGA Technologies (NASDAQ:SIGA) antiviral treatment ...

It is fair to say that the year 2024 was a 'dramatic' one, in which two major life-threatening epidemics were recorded but safely controlled and key achievements were registered in Rwanda's efforts to ...

The second and third cases are Saudi Arabia returnees. Doctors warn further cases may emerge as only symptomatic individuals ...

The World Health Organization (WHO) said Monday it is facing a critical funding gap of 11.1 million U.S. dollars to scale up ...

President Museveni has cautioned Ugandans to be on high alert and implement preventive measures against the Mpox disease ...

The survey of adults in 6 African nations finds 33% are reluctant to receive the mpox vaccine and 39% of parents are ...

SIGA Technologies (SIGA) stock gains as Japan approves antiviral Tepoxx as a treatment for orthopoxviruses including mpox.

Mpox disease remains as a public health emergency of international concern (PHEIC) as per WHO, take a look at how mpox spread ...

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovirimat) for the treatment of smallpox, mpox and cowpox.

The hands of a patient with a skin rash caused by the mpox virus are pictured at the treatment centre of Vijana Hospital in ...